Statements Of Consolidated Cash Flows (USD $) In Millions, unless otherwise specified	3 Months Ended
	Sep. 30, 2012		Sep. 30, 2011
Cash Flows from Operating Activities:
Net earnings	$ 305.3		$ 302.7
Adjustments to reconcile net earnings to cash flows provided by operating activities:
Depreciation and amortization	78.3		78.9
Deferred income taxes	7.1		9.8
Stock-based compensation expense	17.6		18.5
Net pension expense	10.9		9.2
Net realized gain from the sales of marketable securities	(4.5)		(4.0)
Net amortization of premiums and accretion of discounts on available-for-sale securities	18.7		12.8
Other	9.7		3.8
Changes in operating assets and liabilities, net of effects from acquisitions and divestitures of businesses:
(Increase)/decrease in accounts receivable	(73.4)		105.9
Increase in other assets	(330.5)		(117.5)
Decrease in accounts payable	(31.4)		(26.5)
Decrease in accrued expenses and other liabilities	(73.0)		(79.2)
Operating activities of discontinued operations	0.1		1.9
Net cash flows (used in)/provided by operating activities	(65.1)		316.3
Cash Flows from Investing Activities:
Purchases of corporate and client funds marketable securities	(765.5)		(1,095.1)
Proceeds from the sales and maturities of corporate and client funds marketable securities	602.5		844.3
Net decrease in restricted cash and cash equivalents held to satisfy client funds obligations	943.6		6,192.2
Capital expenditures	(30.5)		(33.4)
Additions to intangibles	(33.5)		(24.0)
Acquisitions of businesses, net of cash acquired	(0.7)		(1.9)
Net cash flows provided by investing activities	715.9		5,882.1
Cash Flows from Financing Activities:
Net decrease in client funds obligations	(1,220.4)		(5,936.9)
Payments of debt	(8.2)		(0.5)
Repurchases of common stock	(194.5)		(249.2)
Proceeds from stock purchase plan and exercises of stock options	80.2		48.9
Dividends paid	(192.1)		(177.7)
Net proceeds from reverse repurchase agreements	441.7		0
Net cash flows used in financing activities	(1,093.3)		(6,315.4)
Effect of exchange rate changes on cash and cash equivalents	11.8		(23.5)
Net change in cash and cash equivalents	(430.7)		(140.5)
Cash and cash equivalents of continuing operations	1,548.1	[1]	1,389.4
Cash and cash equivalents of continuing operations	$ 1,117.4	[1]	$ 1,248.9

[1] As of September 30, 2012, $439.4 million of long-term marketable securities and $3.3 million of cash and cash equivalents have been pledged as collateral under the Company's reverse repurchase agreements (see Note 12).